Anest. intenziv. Med. 2008;19(4):203-209

Acute disseminated encephalomyelitis (ADEM) - Case ReportIntesive Care Medicine - Case Report

Dostálová Vlasta*, Dostál Pavel, Černý Vladimír
Klinika anesteziologie, resuscitace a intenzivní medicíny, Fakultní nemocnice Hradec Králové

Acute disseminated encephalomyelitis (ADEM) is an immune-mediated demyelinisation of the brain and spinal cord, precipitated by a infection or vaccination. In the past ADEM was a rare disease with higher incidence recently. Although history, clinical and radiological presentations are typical for this disease, the diagnosis is made per exclusionem. ADEM requiring ICU admission is a severe disease causing high mortality and persistent disability. Authors describe course of illness in one patient, diagnostic process a and therapy with corticosteroids, IVIG a plasmapheresis.

Keywords: acute disseminated encephalomyelitis; intensive care; corticoterapy; IVIG; plasmapheresis

Received: May 12, 2008; Accepted: June 13, 2008; Published: August 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vlasta D, Dostál P, Černý V. Acute disseminated encephalomyelitis (ADEM) - Case Report. Anest. intenziv. Med. 2008;19(4):203-209.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Tenembaum, S. et al. International Pediatric MS Study Group. Acute disseminated encephalomyelitis. Neurology, 2007, 68, 16, p. 23-36. Go to original source... Go to PubMed...
    2. Dale, R. C. et al. Early relapse risk after a first CNS inflammatory demyelination episode: examining international consensus definitions. Dev. Med. Child Neurol., 2007, 49, 12, p. 887-893. Go to original source... Go to PubMed...
    3. Cohen, O. et al. Recurrence of acute disseminated encephalomyelitis at the previously affected brain site. Arch. Neurol., 2001, 58, 5, p. 797-801. Go to original source... Go to PubMed...
    4. Bennetto, L. et al. Encephalomyelitis inflammatory/post-infectious. J. Neurol. Neurosurg. Psychiatry, 2004, 75, p. 22-28. Dostupné na: http://jnnp.bmj.com/cgi/content/full/ 75/suppl_ 1/i22. Go to original source...
    5. Menge, T. et al. Acute disseminated encephalomyelitis: an acute hit against the brain. Curr. Opin. Neurol., 2007, 20, 3, p. 247-254. Go to original source... Go to PubMed...
    6. Robert, R. et al. Acute Disseminated Encephalomyelitis. Article Last Updated, 2007, 12 doi:10.1136/jnnp.2004.045500
    7. Menge, T. et al. Acute Disseminated Encephalomyelitis. An Update. Arch. Neurol., 2005, 62, p. 1673-1680. Go to original source... Go to PubMed...
    8. Plesner, A. M. et al. Neurological complications to vaccination against Japanese encephalitis. Eur. J. Neurol., 1998, 5, p. 479-485. Go to original source... Go to PubMed...
    9. Chopra, B. et al. CSF Beta-1 Globulin - A Potential Marker in Differentiating Multiple Sclerosis and Acute Disseminated Encephalomyelitis: A Preliminary Study. Code Number: ni02011. Dostupné na: http://www.neurologyindia.com
    10. Schwarz, S. et al. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology, 2001, 56, p.1313-1318. Go to original source... Go to PubMed...
    11. Maramattom, B. V. et al. Clinical features and outcome of acute disseminated encephalomyelitis (ADEM): An outlook from South India. Ann. Indian. Acad. Neurol., 2006, 9, p. 20-24. Dostupné na: http://www.annalsofian.org/text.asp?2006/9/1/20/22817 Go to original source...
    12. Rossi, A. Imaging of acute disseminated encephalomyelitis. Neuroimaging Clin. N. Am., 2008, 18, 1, p. 149-161. Go to original source... Go to PubMed...
    13. Sekula, R. F. et al. Central brain herniation secondary to fulminant acute disseminated encephalomyelitis: implications for neurosurgical management. Case report. J. Neurosurg., 2006, 105, 3, p. 472-474. Go to original source... Go to PubMed...
    14. Ravaglia, S. et al. Severe steroid-resistant post-infectious encephalomyelitis: general features and effects of IVIg. J. Neurol., 2007, 254, 11, p. 1518-1523. Go to original source... Go to PubMed...
    15. Lu, R. P. et al. Combination regimen of methylprednisolone, IV immunoglobulin, and plasmapheresis early in the treatment of acute disseminated encephalomyelitis. J. Clin. Apher., 2006, 21, 4, p. 260-265. Go to original source... Go to PubMed...
    16. Lin, CH. et al. Acute disseminated encephalomyelitis: a follow-up study in Taiwan. J. Neurol. Neurosurg. Psychiatry, 2007, 78, 2, p. 162-167. Go to original source... Go to PubMed...
    17. Sonneville, R. et al. Acute disseminated encephalomyelitis in the intensive care unit: clinical features and outcome of 20 adults. Intensive Care Med., 2008, 34, 3, p. 528-532. Go to original source... Go to PubMed...
    18. Tenembaum, S. et al. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology, 2002, 59, p. 1224-31. Go to original source... Go to PubMed...
    19. Axer, H. et al. Initial DWI and ADC imaging may predict outcome in acute disseminated encephalomyelitis: report of two cases of brain stem encephalitis. J. Neurol. Neurosurg. Psychiatry, 2005, 76, p. 996-998. Dostupné na: http://jnnp.bmj.com/cgi/content/full/76/7/996. Go to original source... Go to PubMed...
    20. Rutchik, J. S. et al. Neurologic issues with solvents. Clin. Occup. Environ. Med., 2004, 4, 4, p. 621-656. Go to original source... Go to PubMed...
    21. Matsuoka, M. Neurotoxicity of organic solvents-recent findings. Brain Nerve, 2007, 59, 6, p. 591-596. Go to PubMed...
    22. Thuomas, K. A. et al. MR imaging in solvent-induced chronic toxic encephalopathy. Acta Radiol., 1996, 37, 2, p. 177-179. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.